Drug Profile
Flunisolide hydrofluoroalkane inhalation - AbbVie
Alternative Names: Aerospan; Flunisolide hemihydrate; Flunisolide HFALatest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Forest Laboratories
- Developer AbbVie
- Class Antiallergics; Antiasthmatics; Pregnadienes; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma